NCT02095691View on ClinicalTrials.gov

RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2015

Conditions
Hypertension, Renal
Interventions
DEVICE

Celsius® ThermoCool® Renal Denervation

The investigational device is indicated for the treatment of resistant hypertension by renal denervation.

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY

NCT02095691 - RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 | Biotech Hunter | Biotech Hunter